Pharmafile Logo
Pharmafocus logo
Advanced Search
james_caggiano

Targazyme snaps up new CEO

September 11, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Targazyme, appointment

Experienced industry executive James Caggiano has been named as the new head of Californian biotech Targazyme, who will take up …

Appointment
astrazeneca_sign_sky

NICE U-turns to approve AstraZeneca’s Tagrisso in two new lung cancer indications

September 11, 2020
Medical Communications, Sales and Marketing AstraZeneca, NICE, Tagrisso

NICE has announced the recommendation of AstraZeneca’s Tagrisso (osimertinib) for routine use on the NHS in England and Wales in …

News

Roche and Novartis fined a collective €444 million in France for abusive practices

September 11, 2020
Medical Communications eye medicine, eye treatment

Novartis and Roche have been fined €444 million in France for abusive practices the companies implemented to push Lucentis over …

News

NICE opts to reject Celgene’s Revlimid for newly diagnosed multiple myeloma after an autologous stem cell transplant

September 11, 2020
Medical Communications, Sales and Marketing Celgene, NICE, Revlimid

It has emerged that NICE has opted to reject Celgene’s Revlimid (lenalidomide) for the maintenance of newly diagnosed multiple myeloma …

News
fda_21

FDA sends warning letters to websites illegally selling opioids

September 11, 2020
Medical Communications

The FDA has issued warning letters to 17 websites for illegally selling unapproved or misbranded opioids.  This is due to …

News
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

September 11, 2020
Medical Communications COVID-19, coronavirus, vaccines

The top 10 news stories this week largely cover COVID-19 vaccines, as hundreds of thousands of people in China have …

News
fda_21_0

FDA approves GlaxoSmithKline’s Trelegy for treating asthma

September 10, 2020
Research and Development Ashtma, inhaler

The FDA has approved a new indication of Trelegy Ellipta for the treatment of asthma and patients with chronic obstructive …

News
800px-astrazeneca_hq_in_cambridge_uk

AstraZeneca Chief Executive says vaccine is still possible this year

September 10, 2020
Research and Development AstraZeneca, Oxford Vaccine, Vaccine, coronavirus vaccine, vaccines

Pascal Soriot, Chief Executive of AstraZeneca, said that the company’s vaccine could still be available this year, despite the clinical …

News
800px-rhesus_macaque_monkey_the_look

Pfizer-BioNTech reports strong immune response in animals to its COVID-19 vaccine

September 10, 2020
Research and Development COVID, Macaques, Monkey, Vaccine

Pfizer-BioNTech announced Wednesday that preliminary preclinical data from mouse and macaque monkey models showed a strong immune response from its …

News
bob_woodward_meets_with_edward_r

President Trump has misled the public on how deadly COVID-19 is, according to Watergate reporter’s tapes

September 10, 2020
Medical Communications All the President's men, Bob Woodward, Trump, Watergate

President Trump knew how much more deadly coronavirus was than the flu, despite public comments saying that the threat of …

News
covid_cell_1_1

Pharmafile.com’s weekly COVID-19 news round-up

September 10, 2020
Business Services

The coronavirus news this week focuses on lockdowns and infections, as England is set to increase lockdown restrictions across the …

News
steen-klysner-jpeg-1

Industry veteran Dr Steen Klysner appointed as Amarna’s new CEO

September 9, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amarna, appointments

Amarna Therapeutics has announced the appointment of a new Chief Executive Officer (CEO), hiring industry veteran Dr Steen Klysner to …

Appointment
1

Ali Fattaey appointed Chief Executive Officer of MetaboMed

September 9, 2020
Research and Development

MetaboMed has appointed Ali Fattaey, Ph.D. as its new Chief Executive Officer.Fattaey has over 20 years experience in the industry. …

Appointment
alexion_sign

Alexion’s Ondexxya approved for NHS Scotland to treat uncontrolled and life-threatening bleeds

September 9, 2020
Research and Development, Sales and Marketing Alexion, NHS, Ondexxya, Scotland, nhs scotland

The Scottish Medicines Consortium (SMC) has given its recommendation to Alexion’s Ondexxya (andexanet alfa) to routine use on NHS Scotland …

News

AstraZeneca slams brakes on COVID-19 vaccine trial over unexplained participant illness

September 9, 2020
Research and Development AstraZeneca, COVID-19, pharma

Global trials for AstraZeneca’s much-hyped COVID-19 vaccine, currently in development in partnership with the University of Oxford, have been halted …

News
800px-informal_meeting_of_ministers_for_foreign_affairs_gymnich

Gatherings of over six people to be banned in England from Monday

September 9, 2020
Research and Development Lockdown, coronavirus

England is set to increase lockdown restrictions across the country after a surge in coronavirus cases.  Currently, most outdoor gatherings …

News
download_1

Roche to start new trials of Ocrevus to defend multiple sclerosis franchise

September 9, 2020
Research and Development MS, MS drug, Roche

Roche is to begin expanding trials of Ocrevus in multiple sclerosis (MS) patients to defend its MS franchise from its …

News
china_v_0_1

Major vaccine manufacturers sign COVID-19 safety pledge

September 9, 2020
Research and Development CDC, FDA, anti vaxx, anti-vaxx, coronavirus vaccine

Nine vaccine manufactures have signed a pledge to uphold ethical standards while producing their treatments for COVID-19.  The companies involved …

News
carter_percy

FibroGen names appointment for newly created Chief Scientific Officer role

September 8, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointments, fibrogen

FibroGen has created the new role of Chief Scientific Officer and appointed Dr Percy Carter to the position, it has …

Appointment
molly_henderson

Advaxis Chief Financial Officer resigns

September 8, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Advaxis

Molly Henderson, the Chief Financial Officer and Executive Vice President of Advaxis, has announced her resignation that will take effect …

Appointment
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026